{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:44:26Z","timestamp":1762101866388},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"South-Eastern Norway Health Authority"},{"name":"Medical Research Foundation, Baerum Hospital"},{"name":"Vestre Viken Hospital Trust"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12872-016-0255-x","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T01:51:30Z","timestamp":1462326690000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Troponin I levels in permanent atrial fibrillation\u2014impact of rate control and exercise testing"],"prefix":"10.1186","volume":"16","author":[{"given":"Anja Wiedswang","family":"Horjen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Reinvik","family":"Ulimoen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Enger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Norseth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingebj\u00f8rg","family":"Seljeflot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Arnesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnljot","family":"Tveit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,4]]},"reference":[{"key":"255_CR1","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.28.10.973","volume":"28","author":"PA Wolf","year":"1978","unstructured":"Wolf PA, Dawber TR, Thomas Jr HE, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology. 1978;28:973\u20137.","journal-title":"Neurology"},{"key":"255_CR2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","volume":"98","author":"EJ Benjamin","year":"1998","unstructured":"Benjamin EJ, Wolf PA, D\u2019Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946\u201352.","journal-title":"Circulation"},{"key":"255_CR3","doi-asserted-by":"crossref","unstructured":"Horjen AW, Ulimoen SR, Enger S, Berge T, Ihle-Hansen H, Norseth J et al. Impact of atrial fibrillation on levels of high-sensitivity troponin I in a 75-year-old population. Scand J Clin Lab Invest.2015;75:308-13.","DOI":"10.3109\/00365513.2015.1011224"},{"key":"255_CR4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.hlc.2014.07.071","volume":"24","author":"IG Webb","year":"2015","unstructured":"Webb IG, Yam ST, Cooke R, Aitken A, Larsen PD, Harding SA. Elevated baseline cardiac troponin levels in the elderly - another variable to consider? Heart Lung Circ. 2015;24:142\u20138.","journal-title":"Heart Lung Circ"},{"key":"255_CR5","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.hrthm.2015.01.020","volume":"12","author":"AA Hussein","year":"2015","unstructured":"Hussein AA, Bartz TM, Gottdiener JS, Sotoodehnia N, Heckbert SR, Lloyd-Jones D, et al. Serial measures of cardiac troponin T levels by a highly sensitive assay and incident atrial fibrillation in a prospective cohort of ambulatory older adults. Heart Rhythm. 2015;12:879\u201385.","journal-title":"Heart Rhythm"},{"key":"255_CR6","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1538-7836.2012.04812.x","volume":"10","author":"V Roldan","year":"2012","unstructured":"Roldan V, Marin F, Diaz J, Gallego P, Jover E, Romera M, et al. High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation. J Thromb Haemost. 2012;10:1500\u20137.","journal-title":"J Thromb Haemost"},{"key":"255_CR7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/eurheartj\/ehq491","volume":"32","author":"EJ Bos van den","year":"2011","unstructured":"van den Bos EJ, Constantinescu AA, van Domburg RT, Akin S, Jordaens LJ, Kofflard MJ. Minor elevations in troponin I are associated with mortality and adverse cardiac events in patients with atrial fibrillation. Eur Heart J. 2011;32:611\u20137.","journal-title":"Eur Heart J"},{"key":"255_CR8","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.111.038729","volume":"125","author":"Z Hijazi","year":"2012","unstructured":"Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, Hohnloser SH, et al. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy. Circulation. 2012;125:1605\u201316.","journal-title":"Circulation"},{"key":"255_CR9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/CIRCULATIONAHA.113.006286","volume":"129","author":"Z Hijazi","year":"2014","unstructured":"Hijazi Z, Siegbahn A, Andersson U, Granger CB, Alexander JH, Atar D, et al. High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Circulation. 2014;129:625\u201334.","journal-title":"Circulation"},{"key":"255_CR10","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/heartjnl-2013-304872","volume":"100","author":"Z Hijazi","year":"2014","unstructured":"Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, Hohnloser SH, et al. Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudy. Heart. 2014;100:1193\u2013200.","journal-title":"Heart"},{"key":"255_CR11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/clc.22281","volume":"37","author":"SR Ulimoen","year":"2014","unstructured":"Ulimoen SR, Enger S, Norseth J, Pripp AH, Abdelnoor M, Arnesen H, et al. Improved rate control reduces cardiac troponin T levels in permanent atrial fibrillation. Clin Cardiol. 2014;37:422\u20137.","journal-title":"Clin Cardiol"},{"key":"255_CR12","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1016\/j.ijcard.2013.03.087","volume":"168","author":"AS Parwani","year":"2013","unstructured":"Parwani AS, Boldt LH, Huemer M, Wutzler A, Blaschke D, Rolf S, et al. Atrial fibrillation-induced cardiac troponin I release. Int J Cardiol. 2013;168:2734\u20137.","journal-title":"Int J Cardiol"},{"key":"255_CR13","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1373\/clinchem.2012.190868","volume":"58","author":"H R\u00f8sj\u00f8","year":"2012","unstructured":"R\u00f8sj\u00f8 H, Kravdal G, H\u00f8iseth AD, J\u00f8rgensen M, Badr P, R\u00f8ysland R, et al. Troponin I measured by a high-sensitivity assay in patients with suspected reversible myocardial ischemia: data from the Akershus Cardiac Examination (ACE) 1 study. Clin Chem. 2012;58:1565\u201373.","journal-title":"Clin Chem"},{"key":"255_CR14","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1042\/CS20110557","volume":"122","author":"R R\u00f8ysland","year":"2012","unstructured":"R\u00f8ysland R, Kravdal G, H\u00f8iseth AD, Nyg\u00e5rd S, Badr P, Hagve TA, et al. Cardiac troponin T levels and exercise stress testing in patients with suspected coronary artery disease: the Akershus Cardiac Examination (ACE) 1 study. Clin Sci (Lond). 2012;122:599\u2013606.","journal-title":"Clin Sci (Lond)"},{"key":"255_CR15","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jacc.2012.12.026","volume":"61","author":"T Omland","year":"2013","unstructured":"Omland T, Pfeffer MA, Solomon SD, de Lemos JA, R\u00f8sj\u00f8 H, Saltyte Benth J, et al. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol. 2013;61:1240\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"255_CR16","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/eurheartj\/ehu188","volume":"35","author":"M Rubini Gimenez","year":"2014","unstructured":"Rubini Gimenez M, Twerenbold R, Reichlin T, Wildi K, Haaf P, Schaefer M, et al. Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction. Eur Heart J. 2014;35:2303\u201311.","journal-title":"Eur Heart J"},{"key":"255_CR17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1373\/clinchem.2014.226936","volume":"61","author":"Z Hijazi","year":"2015","unstructured":"Hijazi Z, Siegbahn A, Andersson U, Lindahl B, Granger CB, Alexander JH, et al. Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy. Clin Chem. 2015;61:368\u201378.","journal-title":"Clin Chem"},{"key":"255_CR18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.amjcard.2012.09.020","volume":"111","author":"SR Ulimoen","year":"2013","unstructured":"Ulimoen SR, Enger S, Carlson J, Platonov PG, Pripp AH, Abdelnoor M, et al. Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation. Am J Cardiol. 2013;111:225\u201330.","journal-title":"Am J Cardiol"},{"key":"255_CR19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0735-1097(97)00150-2","volume":"30","author":"RJ Gibbons","year":"1997","unstructured":"Gibbons RJ, Balady GJ, Beasley JW, Bricker JT, Duvernoy WF, Froelicher VF, et al. ACC\/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol. 1997;30:260\u2013311.","journal-title":"J Am Coll Cardiol"},{"key":"255_CR20","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/eurheartj\/eht429","volume":"35","author":"SR Ulimoen","year":"2014","unstructured":"Ulimoen SR, Enger S, Pripp AH, Abdelnoor M, Arnesen H, Gjesdal K, et al. Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation. Eur Hear J. 2014;35:517\u201324.","journal-title":"Eur Hear J"},{"key":"255_CR21","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1161\/01.CIR.94.7.1585","volume":"94","author":"RS Bubien","year":"1996","unstructured":"Bubien RS, Knotts-Dolson SM, Plumb VJ, Kay GN. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation. 1996;94:1585\u201391.","journal-title":"Circulation"},{"key":"255_CR22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ahj.2004.03.065","volume":"149","author":"LS Jenkins","year":"2005","unstructured":"Jenkins LS, Brodsky M, Schron E, Chung M, Rocco Jr T, Lader E, et al. Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2005;149:112\u201320.","journal-title":"Am Heart J"},{"key":"255_CR23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1373\/clinchem.2011.165795","volume":"58","author":"FS Apple","year":"2012","unstructured":"Apple FS, Collinson PO. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem. 2012;58:54\u201361.","journal-title":"Clin Chem"},{"key":"255_CR24","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1161\/CIRCULATIONAHA.107.708529","volume":"116","author":"KM Eggers","year":"2007","unstructured":"Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality. Circulation. 2007;116:1907\u201314.","journal-title":"Circulation"},{"key":"255_CR25","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1373\/clinchem.2010.159350","volume":"57","author":"SK Agarwal","year":"2011","unstructured":"Agarwal SK, Avery CL, Ballantyne CM, Catellier D, Nambi V, Saunders J, et al. Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study. Clin Chem. 2011;57:891\u20137.","journal-title":"Clin Chem"},{"key":"255_CR26","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1373\/clinchem.2012.192716","volume":"58","author":"FS Apple","year":"2012","unstructured":"Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem. 2012;58:1574\u201381.","journal-title":"Clin Chem"},{"key":"255_CR27","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1373\/clinchem.2009.132654","volume":"56","author":"E Giannitsis","year":"2010","unstructured":"Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56:254\u201361.","journal-title":"Clin Chem"},{"key":"255_CR28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/10641963.2012.689044","volume":"35","author":"S Hoshide","year":"2013","unstructured":"Hoshide S, Fukutomi M, Eguchi K, Watanabe T, Kabutoya T, Kario K. Change in high-sensitive cardiac troponin T on hypertensive treatment. Clin Exp Hypertens. 2013;35:40\u20134.","journal-title":"Clin Exp Hypertens"},{"key":"255_CR29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jacc.2010.03.037","volume":"56","author":"R Shave","year":"2010","unstructured":"Shave R, Baggish A, George K, Wood M, Scharhag J, Whyte G, et al. Exercise-induced cardiac troponin elevation: evidence, mechanisms, and implications. J Am Coll Cardiol. 2010;56:169\u201376.","journal-title":"J Am Coll Cardiol"},{"key":"255_CR30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1067\/mhj.2002.123313","volume":"144","author":"O Schulz","year":"2002","unstructured":"Schulz O, Kromer A. Cardiac troponin I: a potential marker of exercise intolerance in patients with moderate heart failure. Am Heart J. 2002;144:351\u20138.","journal-title":"Am Heart J"},{"key":"255_CR31","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3109\/1354750X.2013.776635","volume":"18","author":"A Axelsson","year":"2013","unstructured":"Axelsson A, Ruwald MH, Dalsgaard M, Rossing K, Steffensen R, Iversen K. Serial measurements of high-sensitivity cardiac troponin T after exercise stress test in stable coronary artery disease. Biomarkers. 2013;18:304\u20139.","journal-title":"Biomarkers"},{"key":"255_CR32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/eurheartj\/ehn504","volume":"30","author":"MS Sabatine","year":"2009","unstructured":"Sabatine MS, Morrow DA, de Lemos JA, Jarolim P, Braunwald E. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur Heart J. 2009;30:162\u20139.","journal-title":"Eur Heart J"},{"key":"255_CR33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1373\/clinchem.2011.171082","volume":"58","author":"PO Collinson","year":"2012","unstructured":"Collinson PO, Heung YM, Gaze D, Boa F, Senior R, Christenson R, et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem. 2012;58:219\u201325.","journal-title":"Clin Chem"},{"key":"255_CR34","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/eurheartj\/ehl233","volume":"27","author":"RJ Shelton","year":"2006","unstructured":"Shelton RJ, Clark AL, Goode K, Rigby AS, Cleland JG. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation. Eur Heart J. 2006;27:2353\u201361.","journal-title":"Eur Heart J"},{"key":"255_CR35","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1016\/j.ijcard.2013.05.047","volume":"168","author":"J Kosiuk","year":"2013","unstructured":"Kosiuk J, Buchta P, Gaspar T, Arya A, Piorkowski C, Rolf S, et al. Prevalence and predictors of worsened left ventricular diastolic dysfunction after catheter ablation of atrial fibrillation. Int J Cardiol. 2013;168:3613\u20135.","journal-title":"Int J Cardiol"},{"key":"255_CR36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.amjcard.2014.05.012","volume":"114","author":"P Kumar","year":"2014","unstructured":"Kumar P, Patel A, Mounsey JP, Chung EH, Schwartz JD, Pursell IW, et al. Effect of left ventricular diastolic dysfunction on outcomes of atrial fibrillation ablation. Am J Cardiol. 2014;114:407\u201311.","journal-title":"Am J Cardiol"},{"key":"255_CR37","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1540-8159.2009.02360.x","volume":"32","author":"D Bakowski","year":"2009","unstructured":"Bakowski D, Wozakowska-Kaplon B, Opolski G. The influence of left ventricle diastolic function on natriuretic peptides levels in patients with atrial fibrillation. Pacing Clin Electrophysiol. 2009;32:745\u201352.","journal-title":"Pacing Clin Electrophysiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0255-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T12:38:34Z","timestamp":1498307914000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-016-0255-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,4]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["255"],"URL":"https:\/\/doi.org\/10.1186\/s12872-016-0255-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,4]]},"article-number":"79"}}